RankingsPricing
  1. US-listed companies
  2. NEUROONE MEDICAL TECHNOLOGIES Corp
  3. Financials
  4. Return on Assets

NEUROONE MEDICAL TECHNOLOGIES CorpNMTC

Market cap
$35.8M
P/E ratio
SummaryFinancials
Period EndReturn on Assets (Million USD)YoY (%)
Sep 30, 2024-182.9+61.34%
Sep 30, 2023-113.4+17.70%
Sep 30, 2022-96.3-38.52%
Sep 30, 2021-156.7-69.60%
Sep 30, 2020-515.5-67.01%
Dec 31, 2016-1,562.5-74.61%
Dec 31, 2015-6,154

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)